New pill shows promise in early hepatitis b trial
NCT ID NCT04536337
First seen Nov 21, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This early-stage study tested a new oral drug called ALG-000184 in 165 people, including healthy volunteers and patients with chronic hepatitis B. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked at whether it can lower hepatitis B virus levels, especially when given with a standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ACS
Auckland, New Zealand
-
CAP Research
Quatre Bornes, Mauritius, 72218, Mauritius
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China
-
PMSI Republican Clinical Hospital "T. Mosneaga", ARENSIA Exploratory Medicine Phase I Unit
Chisinau, Moldova
-
Prince of Wales
Shatin, Hong Kong
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Saint Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065, Australia
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
-
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
-
Western Health
Footscray, Victoria, 3011, Australia
Conditions
Explore the condition pages connected to this study.